Clinical Use Of Antiviral Drugs

Clinical Use Of Antiviral Drugs Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Clinical Use Of Antiviral Drugs book. This book definitely worth reading, it is an incredibly well-written.

Clinical Use of Antiviral Drugs

Author : Erik de Clercq
Publisher : Springer Science & Business Media
Page : 420 pages
File Size : 53,7 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9781461317159

Get Book

Clinical Use of Antiviral Drugs by Erik de Clercq Pdf

Antiviral chemotherapy has come of age, and, after an initial slow pro gress, the development of new antiviral agents has proceeded at a more rapid pace and the perspectives for their clinical use have increased considerably. Now, 25 years after the first antiviral assay (idoxuridine) was introduced in the clinic, it is fitting to commemorate the beginning of the antivirals' era. In its introductory chapter B.E. Juel-Jensen touches on what may be con sidered as five of the most fundamental requirements of an antiviral drug : efficacy, relative non-toxicity, easy solubility, ready availability and rea sonable cost. Surely, the antiviral drugs that have so far been used in the clinic could still be improved upon as one or more of these five essential demands are concerned. How is all began is narrated by W.H. Prusoff. The first antiviral drugs to be used in humans were methisazone and idoxuridine, the former, which is now of archival interest, in the prevention of smallpox, the latter, which was approved for clinical use in the United States in 1962, for the topical treatment of herpetic keratitis. In terms of potency, also because of solubility reasons, idoxuridine has been superseded by trifluridine in the topical treatment of herpes simplex epithelial keratitis. H.E. Kaufman did not find trifluridine or acyclovir ef fective in the treatment of deep stromal keratitis or iritis and he reckons that other antiviral drugs (i.e. bromovinyldeoxyuridine) would not be effec tive either.

Human Herpesviruses

Author : Ann Arvin,Gabriella Campadelli-Fiume,Edward Mocarski,Patrick S. Moore,Bernard Roizman,Richard Whitley,Koichi Yamanishi
Publisher : Cambridge University Press
Page : 1325 pages
File Size : 41,9 Mb
Release : 2007-08-16
Category : Medical
ISBN : 9781139461641

Get Book

Human Herpesviruses by Ann Arvin,Gabriella Campadelli-Fiume,Edward Mocarski,Patrick S. Moore,Bernard Roizman,Richard Whitley,Koichi Yamanishi Pdf

This comprehensive account of the human herpesviruses provides an encyclopedic overview of their basic virology and clinical manifestations. This group of viruses includes human simplex type 1 and 2, Epstein–Barr virus, Kaposi's Sarcoma-associated herpesvirus, cytomegalovirus, HHV6A, 6B and 7, and varicella-zoster virus. The viral diseases and cancers they cause are significant and often recurrent. Their prevalence in the developed world accounts for a major burden of disease, and as a result there is a great deal of research into the pathophysiology of infection and immunobiology. Another important area covered within this volume concerns antiviral therapy and the development of vaccines. All these aspects are covered in depth, both scientifically and in terms of clinical guidelines for patient care. The text is illustrated generously throughout and is fully referenced to the latest research and developments.

Chemotherapy of Viral Infections

Author : P E. Came,L. A. Caliguiri
Publisher : Springer Science & Business Media
Page : 580 pages
File Size : 52,9 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9783642684876

Get Book

Chemotherapy of Viral Infections by P E. Came,L. A. Caliguiri Pdf

" . . . the motto for the therapeutics of the future will have to be de sedibus et causis pharmacorum. " P. EHRLICH, 1909 Exciting events in the basic disciplines of virology, immunology, and pharmacology continue to advance the understanding of the pathogenesis and control of virus diseases. At the same time, the rational development of antiviral agents is attracting, to an increasing extent, the interest of workers in other disciplines. Improvements in technology facilitate the definition of potential target sites for antiviral intervention and unmask new viral and host genes. The outcome is a further steady development of new antiviral agents which approach the "magic bullets" first proposed by PAUL EHRLICH. Remarkable advances in protein synthetic methods that yield polypeptides which inhibit active sites of viral proteins have aided substantially in the basic and clinical study of these antiviral agents. In addition, the extremely rapid progression in recombinant DNA techniques, leading to the synthesis of large quantities of gene products, is also increasing our opportunities at a dashing pace. New information and developing technology facilitate research on the mechanism of action, toxicity, pharmacokinetics, and pharmacodynamics of new agents. The list of clinically effective antiviral agents is expanding and the number of potentially useful compounds is growing rapidly. This book is a combined theoretical text and practical manual which, it is hoped, will be of use to all who have an interest in virus diseases, particularly scientists, physicians and graduate students.

Clinical Use of Antiviral Drugs

Author : Erik De Clercq
Publisher : Unknown
Page : 436 pages
File Size : 51,5 Mb
Release : 1988-01-31
Category : Electronic
ISBN : 1461317169

Get Book

Clinical Use of Antiviral Drugs by Erik De Clercq Pdf

Antiviral Drugs

Author : Wieslaw M. Kazmierski
Publisher : John Wiley & Sons
Page : 468 pages
File Size : 49,9 Mb
Release : 2011-08-23
Category : Medical
ISBN : 9780470455630

Get Book

Antiviral Drugs by Wieslaw M. Kazmierski Pdf

This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral drugs and compounds in advanced clinical development. Organized by a virus (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by top academic and industrial authorities in the field, the book provides a unique opportunity to study, understand and apply discovery and development principles and learning without the need for an individual to research, analyze and synthesize all immense sourcing references. Topics showcase challenges and solutions of issues encountered, offering tremendous experience accumulated over many years of research that will be particularly useful to basic and bench scientists as well as clinicians as they continue discovering and developing new drugs and therapies.

Antiviral Drugs

Author : Patrick Arbuthnot
Publisher : BoD – Books on Demand
Page : 210 pages
File Size : 40,9 Mb
Release : 2012-03-14
Category : Medical
ISBN : 9789535102564

Get Book

Antiviral Drugs by Patrick Arbuthnot Pdf

The articles that appear in Antiviral Drugs - Aspects of Clinical Use and Recent Advances cover several topics that reflect the varied mechanisms of viral disease pathogenesis and treatment. Clinical management and new developments in the treatment of virus-related diseases are the two main sections of the book. The first part reviews the treatment of hepatitis C virus infection, the management of virus-related acute retinal necrosis, the use of leflunomide therapy in renal transplant patients, and mathematical modeling of HIV-1 treatment responses. Basic research topics are dealt with in the second half of the book. New developments in the treatment of the influenza virus, the use of animal models for HIV-1 drug development, the use of single chain camelid antibodies against negative strand RNA viruses, countering norovirus infection, and the use of plant extracts to treat herpes simplex virus infection are described. The content of the book is not intended to be comprehensive, but aims to provide the reader with insights into selected aspects of established and new viral therapies.

Antiviral Chemotherapy

Author : D. J. Jeffries,Erik De Clercq
Publisher : Unknown
Page : 614 pages
File Size : 48,5 Mb
Release : 1995-07-11
Category : Medical
ISBN : UOM:39015034910474

Get Book

Antiviral Chemotherapy by D. J. Jeffries,Erik De Clercq Pdf

Considerable advances have been made in the treatment of antiviral diseases over the last decade. Several new drugs have been introduced while new clinical information has been gathered on the efficacy of existing drugs. This study aims to provide an examination of the basic science (drug formulae, structure and biochemical activity) and clinical information (usage and efficacy) on chemotherapy, as well as describing future potentials.

Kucers' The Use of Antibiotics

Author : M. Lindsay Grayson,Sara E. Cosgrove,Suzanne Crowe,William Hope,James S. McCarthy,John Mills,Johan W. Mouton,David L. Paterson
Publisher : CRC Press
Page : 4894 pages
File Size : 54,5 Mb
Release : 2017-10-02
Category : Medical
ISBN : 9781498747967

Get Book

Kucers' The Use of Antibiotics by M. Lindsay Grayson,Sara E. Cosgrove,Suzanne Crowe,William Hope,James S. McCarthy,John Mills,Johan W. Mouton,David L. Paterson Pdf

Kucers’ The Use of Antibiotics is the definitive, internationally-authored reference, providing everything that the infectious diseases specialist and prescriber needs to know about antimicrobials in this vast and rapidly developing field. The much-expanded Seventh Edition comprises 4800 pages in 3 volumes in order to cover all new and existing therapies, and emerging drugs not yet fully licensed. Concentrating on the treatment of infectious diseases, the content is divided into four sections - antibiotics, anti-fungal drugs, anti-parasitic drugs, and anti-viral drugs - and is highly structured for ease of reference. Each chapter is organized in a consistent format, covering susceptibility, formulations and dosing (adult and pediatric), pharmacokinetics and pharmacodynamics, toxicity, and drug distribution, with detailed discussion regarding clinical uses - a feature unique to this title. Compiled by an expanded team of internationally renowned and respected editors, with expert contributors representing Europe, Africa, Asia, Australia, South America, the US, and Canada, the Seventh Edition adopts a truly global approach. It remains invaluable for anyone using antimicrobial agents in their clinical practice and provides, in a systematic and concise manner, all the information required when prescribing an antimicrobial to treat infection.

Assessment of Future Scientific Needs for Live Variola Virus

Author : Committee on the Assessment of Future Scientific Needs for Variola Virus,Institute of Medicine
Publisher : National Academies Press
Page : 126 pages
File Size : 50,7 Mb
Release : 1999-05-14
Category : Medical
ISBN : 9780309596985

Get Book

Assessment of Future Scientific Needs for Live Variola Virus by Committee on the Assessment of Future Scientific Needs for Variola Virus,Institute of Medicine Pdf

In 1980, the World Health Organization (WHO) officially declared that smallpox had been eradicated. In 1986, WHO's international Ad Hoc Committee on Orthopox Virus Infections unanimously recommended destruction of the two remaining official stocks of variola virus, one at the Centers for Disease Control and Prevention and the other at the VECTOR laboratory in Siberia. In June 1999, WHO decided to delay the destruction of these stocks. Informing that decision was Assessment of Future Scientific Needs for Variola Virus, which examines: -- Whether the sequenced variola genome, vaccinia, and monkey pox virus are adequate for future research or whether the live variola virus itself is needed to assist in the development of antiviral therapies. -- What further benefits, if any, would likely be gained through the use of variola in research and development efforts related to agent detection, diagnosis, prevention, and treatment. -- What unique potential benefits, if any, the study of variola would have in increasing our fundamental understanding of the biology, host-agent interactions, pathogenesis, and immune mechanisms of viral diseases.

Clinical Use of Anti-infective Agents

Author : Robert W. Finberg,Roy Guharoy
Publisher : Springer Nature
Page : 296 pages
File Size : 41,5 Mb
Release : 2021-07-23
Category : Medical
ISBN : 9783030674595

Get Book

Clinical Use of Anti-infective Agents by Robert W. Finberg,Roy Guharoy Pdf

This second edition of Clinical Use of Anti-Infective Agents provides a comprehensive overview of current approaches to using drugs to treat infections, including historical perspectives, definitions, and discussion of pharmacokinetics and pharmacodynamics and their uses. It includes a detailed explanation of different classes of drugs, outlining their spectrum, pharmacokinetics, side effects, and dosing in clinical settings. This book has been designed as a reference tool for pharmacists, clinicians, nurse practitioners, and clinical microbiologists, as well as a teaching vehicle for students studying infection and patient treatment. Each section includes references allowing for in-depth study of specific agents, Q&As, and illustrative case studies accompanied by commentary on how to approach patients and organisms, optimal methods of making a diagnosis, and prescribing treatment.

Current Issues in Molecular Virology

Author : Victor Romanowski
Publisher : BoD – Books on Demand
Page : 297 pages
File Size : 45,6 Mb
Release : 2013-11-20
Category : Science
ISBN : 9789535112075

Get Book

Current Issues in Molecular Virology by Victor Romanowski Pdf

This book is a collection of chapters dealing with examples of RNA and DNA viruses, and issues such as how these gene packages have learnt to take advantage of their hosts, molecular recognition events that hosts may use to counterattack the viruses, and how researchers have developed strategies to use viruses or their parts as tools for different purposes.

Red Book

Author : Larry K. Pickering,American Academy of Pediatrics. Committee on Infectious Diseases
Publisher : Unknown
Page : 0 pages
File Size : 54,7 Mb
Release : 2012
Category : Medical
ISBN : 158110703X

Get Book

Red Book by Larry K. Pickering,American Academy of Pediatrics. Committee on Infectious Diseases Pdf

Developed by the AAP (American Academy of Pediatrics) Committee on Infectious Diseases in conjunction with the CDC (Centers for disease control), the FDA (Food and drug administration), and other leading institutions with contributions from hundreds of physicians nationwide, the newly revised and updated 2012 Red Book continues the tradition of excellence with the latest findings and clinical recommendations on the manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood conditions. [Ed.].

Antiviral Strategies

Author : Hans-Georg Kräusslich,Ralf Bartenschlager
Publisher : Springer Science & Business Media
Page : 386 pages
File Size : 54,7 Mb
Release : 2008-12-02
Category : Medical
ISBN : 9783540790860

Get Book

Antiviral Strategies by Hans-Georg Kräusslich,Ralf Bartenschlager Pdf

A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost effectiveness. Individual chapters address in more detail all available drug classes and outline new approaches currently under development.

Antiviral Chemotherapy 5

Author : John Mills,Paul A. Volberding,Lawrence Corey
Publisher : Springer Science & Business Media
Page : 266 pages
File Size : 51,7 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9781461547433

Get Book

Antiviral Chemotherapy 5 by John Mills,Paul A. Volberding,Lawrence Corey Pdf

Scientists and clinicians attending the last "New Directions in Antiviral Therapy" conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.

Successful Strategies for the Discovery of Antiviral Drugs

Author : Manoj C. Desai,Nicholas A. Meanwell
Publisher : Royal Society of Chemistry
Page : 544 pages
File Size : 46,8 Mb
Release : 2013-06-17
Category : Science
ISBN : 9781849737814

Get Book

Successful Strategies for the Discovery of Antiviral Drugs by Manoj C. Desai,Nicholas A. Meanwell Pdf

The antiviral therapeutic area continues to rapidly generate meaningful new chemical entities; for example, for HIV alone more than 25 drugs have been approved, and in the next few years many individual drugs and single tablet regimens will be approved for the treatment of hepatitis C virus infection. The increasing success in the antiviral area could be due to targeting drugs at "non-self" genomes and to the patient population that is tolerant of manageable side effects and adaptable to inconvenient dosing. Aimed at medicinal chemists and emerging drug discovery scientists, the book is organized according to the various strategies deployed for the discovery and optimization of initial lead compounds. This book focuses on capturing tactical aspects of problem solving in antiviral drug design, an approach that holds special appeal for those engaged in antiviral drug development, but also appeals to the broader medicinal chemistry community based on its focus on tactical aspects of drug design.